Fardokht A. Abulwerdi

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Mcl-1, an antiapoptotic member of the Bcl-2 family of proteins, is a validated and attractive target for cancer therapy. Overexpression of Mcl-1 in many cancers results in disease progression and resistance to current chemotherapeutics. Utilizing high-throughput screening, compound 1 was identified as a selective Mcl-1 inhibitor and its binding to the BH3(More)
  • 1